Ishares Healthcare Invesco Nasdaq: 2026 Investment Bet
Two popular healthcare ETFs sit at the crossroads of broad exposure and biotech precision. This guide helps you decid...
Biotech
Biotech insights await. This page curates 5 articles on Tempus, Moderna, Praxis, ImmunityBio and market moves to help you evaluate stocks and sharpen your portfolio strategy.
134 articlesCathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
UCB (ucb) 2026 Earnings Call Preview for Investors
As UCB prepares to reveal Q2 results, investors should focus on revenue mix, pipeline progress, and margin resilience...
Reasons AbbVie Stock Like There’s No Tomorrow: 3 Key Drivers
Looking at AbbVie today, investors often ask what makes reasons abbvie stock like this compelling. This article break...
Jeff Bezos Backed Grail: Early Bet or Costly Call?
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
Which Better Choice Healthcare for Investors: IYH or BBH
Choosing between a broad healthcare ETF and a biotech-focused fund can shape risk, cost, and growth. This guide break...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Vertex Pharmaceuticals Just Made a Major Move: Is the Stock a Buy?
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Invesco Pharmaceuticals State Street ETFs: Which Is Better?
Two popular healthcare ETFs, PJP and XBI, offer very different paths to exposure. This guide breaks down the trade-of...
Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...